Exploration of antimicrobial potential of pyrazolo[3,4-b]pyridine scaffold bearing benzenesulfonamide and trifluoromethyl moieties

[1]  W. Hamama,et al.  Synthesis, antioxidant, and antitumor evaluation of certain new N-substituted-2-amino-1,3,4-thiadiazoles , 2013, Medicinal Chemistry Research.

[2]  P. Sharma,et al.  Heteroaromatic analogues of 1,5-diarylpyrazole class as anti-inflammatory agents , 2012, Medicinal Chemistry Research.

[3]  P. Sharma,et al.  Synthesis and biological evaluation of some pyrazole derivatives as anti-inflammatory–antibacterial agents , 2012, Medicinal Chemistry Research.

[4]  P. Sharma,et al.  Synthesis of 1-(4-aminosulfonylphenyl)-3,5-diarylpyrazoline derivatives as potent antiinflammatory and antimicrobial agents , 2012, Medicinal Chemistry Research.

[5]  Virender Kumar,et al.  Multi-component solvent-free versus stepwise solvent mediated reactions: Regiospecific formation of 6-trifluoromethyl and 4-trifluoromethyl-1H-pyrazolo(3,4-b)pyridines , 2012 .

[6]  B. Blass.  Fused heterocyclic compounds as ion channel modulators: patent highlight. , 2012, ACS Medicinal Chemistry Letters.

[7]  P. Nielsen,et al.  Sulfonamide bearing oligonucleotides: simple synthesis and efficient RNA recognition. , 2012, Bioorganic & medicinal chemistry.

[8]  Tao Chen,et al.  Multicomponent approaches to 8-carboxylnaphthyl-functionalized pyrazolo[3,4-b]pyridine derivatives. , 2012, Organic & biomolecular chemistry.

[9]  N. Parekh,et al.  Antituberculosis and antibacterial evaluations of some novel phenyl pyrazolone-substituted 1h-benzo[g]pyrazolo[3,4-b]quinoline-3-ylamine derivatives , 2012, Medicinal Chemistry Research.

[10]  Gulay Zengin,et al.  Synthesis of sulfanilamide derivatives and investigation of in vitro inhibitory activities and antimicrobial and physical properties. , 2011, Bioorganic chemistry.

[11]  M. Al-Dosari,et al.  Synthesis and in vitro anticancer evaluation of some novel hexahydroquinoline derivatives having a benzenesulfonamide moiety. , 2011, European journal of medicinal chemistry.

[12]  P. Sharma,et al.  Synthesis and biological evaluation of some 4-functionalized-pyrazoles as antimicrobial agents. , 2011, European journal of medicinal chemistry.

[13]  P. Sharma,et al.  Synthesis and anti-inflammatory evaluation of some pyrazolo[3,4-b]pyridines , 2011, Medicinal Chemistry Research.

[14]  Ding-Yah Yang,et al.  Synthesis of coumarin/phenanthridine-fused heterocycles and their photochemical and thermochromic properties. , 2011, Organic Letters.

[15]  F. Ragab,et al.  In vitro anticancer screening and radiosensitizing evaluation of some new quinolines and pyrimido[4,5-b]quinolines bearing a sulfonamide moiety. , 2010, European journal of medicinal chemistry.

[16]  P. Collins,et al.  Synthesis and Biological Evaluation of the 1,5-Diarylpyrazole Class of Cyclooxygenase-2 Inhibitors: Identification of 4-(5-(4-Methylphenyl)-3- (trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide (SC-58635, Celecoxib). , 2010 .

[17]  P. Sharma,et al.  Synthesis and biological evaluation of some pyrazolylpyrazolines as anti-inflammatory-antimicrobial agents. , 2010, European journal of medicinal chemistry.

[18]  S. Mutha,et al.  Synthesis and antimicrobial studies on novel sulfonamides containing 4-azidomethyl coumarin. , 2010, European journal of medicinal chemistry.

[19]  T. Ali.  Synthesis of some novel pyrazolo[3,4-b]pyridine and pyrazolo[3,4-d]pyrimidine derivatives bearing 5,6-diphenyl-1,2,4-triazine moiety as potential antimicrobial agents. , 2009 .

[20]  I. Ojima.  Fluorine in medicinal chemistry and chemical biology , 2009 .

[21]  S. Selivanov,et al.  α-aminoazoles in synthesis of heterocycles: III. 4-trifluoromethylpyrazolo[3,4-b]pyridines: Synthesis and structure , 2009 .

[22]  H. Castro,et al.  Antibacterial profile against drug-resistant Staphylococcus epidermidis clinical strain and structure-activity relationship studies of 1H-pyrazolo[3,4-b]pyridine and thieno[2,3-b]pyridine derivatives. , 2008, Bioorganic & medicinal chemistry.

[23]  S. Bharate,et al.  Synthesis and evaluation of pyrazolo[3,4-b]pyridines and its structural analogues as TNF-alpha and IL-6 inhibitors. , 2008, Bioorganic & medicinal chemistry.

[24]  M. Lindvall,et al.  Pyrazolopyridines as a novel structural class of potent and selective PDE4 inhibitors. , 2008, Bioorganic & medicinal chemistry letters.

[25]  S. Swallow,et al.  Fluorine in medicinal chemistry. , 2015, Progress in medicinal chemistry.

[26]  S. Selivanov,et al.  α-aminoazoles in synthesis of heterocycles: III. 4-trifluoromethylpyrazolo[3,4-b]pyridines: Synthesis and structure , 2008 .

[27]  D. Ferreira,et al.  Synthesis and antiviral activity of new 4-(phenylamino)/4-[(methylpyridin-2-yl)amino]-1-phenyl-1H-pyrazolo[3,4-b]pyridine-4-carboxylic acids derivatives , 2007, Medicinal Chemistry Research.

[28]  Ismael Zamora,et al.  CYP2C9 structure-metabolism relationships: optimizing the metabolic stability of COX-2 inhibitors. , 2007, Journal of medicinal chemistry.

[29]  S. Emanuel,et al.  Synthesis and evaluation of pyrazolo[3,4-b]pyridine CDK1 inhibitors as anti-tumor agents. , 2007, Bioorganic & medicinal chemistry letters.

[30]  M. Schlosser.  CF(3)-bearing aromatic and heterocyclic building blocks. , 2006, Angewandte Chemie.

[31]  M. Schlosser.  CF(3)-bearing aromatic and heterocyclic building blocks. , 2006, Angewandte Chemie.

[32]  M. Shafique,et al.  Synthesis, Antimicrobial and Anti‐HIV Activity of Some Novel Benzenesulfonamides Bearing 2,5‐Disubstituted‐1,3,4‐Oxadiazole Moiety , 2006 .

[33]  W. D. Loehle,et al.  Keto-enol and enol-enol tautomerism in trifluoromethyl-β-diketones , 2006 .

[34]  E. Barreiro,et al.  Design, synthesis, and pharmacological evaluation of new neuroactive pyrazolo[3,4-b]pyrrolo[3,4-d]pyridine derivatives with in vivo hypnotic and analgesic profile. , 2006, Bioorganic & medicinal chemistry.

[35]  E. AUGUSTYNOWICZ-KOPEĆ,et al.  Synthesis and antibacterial activity of 1H-pyrazolo[3,4-b]pyrazine and -pyridine derivatives. , 2005, Farmaco.

[36]  O. Prakash,et al.  Synthesis of Some Novel Fluorinated Pyrazolo[3,4‐b]Pyridines , 2004 .

[37]  L. Leon,et al.  Antileishmanial pyrazolopyridine derivatives: synthesis and structure-activity relationship analysis. , 2004, Journal of medicinal chemistry.

[38]  Y. K. Rao,et al.  Polar substitutions in the benzenesulfonamide ring of celecoxib afford a potent 1,5-diarylpyrazole class of COX-2 inhibitors. , 2004, Bioorganic & medicinal chemistry letters.

[39]  A. Naylor,et al.  6-aryl-pyrazolo[3,4-b]pyridines: potent inhibitors of glycogen synthase kinase-3 (GSK-3). , 2003, Bioorganic & Medicinal Chemistry Letters.

[40]  A. Naylor,et al.  6-heteroaryl-pyrazolo[3,4-b]pyridines: potent and selective inhibitors of glycogen synthase kinase-3 (GSK-3). , 2003, Bioorganic & medicinal chemistry letters.

[41]  J. Tokarski,et al.  1H-Pyrazolo[3,4-b]pyridine inhibitors of cyclin-dependent kinases: highly potent 2,6-Difluorophenacyl analogues. , 2003, Bioorganic & Medicinal Chemistry Letters.

[42]  R. Ife,et al.  5-aryl-pyrazolo[3,4-b]pyridazines: potent inhibitors of glycogen synthase kinase-3 (GSK-3). , 2003, Bioorganic & medicinal chemistry letters.

[43]  John S Tokarski,et al.  1H-Pyrazolo[3,4-b]pyridine inhibitors of cyclin-dependent kinases. , 2003, Bioorganic & medicinal chemistry letters.

[44]  E. Barreiro,et al.  Molecular modeling of novel 1H-pyrazolo[3,4-b]pyridine derivatives designed as isosters of the antimalarial mefloquine , 2002 .

[45]  C. Esimone,et al.  Evaluation of extracts of the root of Landolphia owerrience for antibacterial activity. , 2001, Journal of ethnopharmacology.

[46]  J. Andrews,et al.  Determination of minimum inhibitory concentrations. , 2001, The Journal of antimicrobial chemotherapy.

[47]  I. Ahmad,et al.  Antimicrobial and phytochemical studies on 45 Indian medicinal plants against multi-drug resistant human pathogens. , 2001, Journal of ethnopharmacology.

[48]  R. S. Rogers,et al.  Synthesis and biological evaluation of the 1,5-diarylpyrazole class of cyclooxygenase-2 inhibitors: identification of 4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benze nesulfonamide (SC-58635, celecoxib). , 1997, Journal of medicinal chemistry.

[49]  J. Campbell,et al.  Synthesis and structure-activity relationships of a series of anxioselective pyrazolopyridine ester and amide anxiolytic agents. , 1989, Journal of medicinal chemistry.

[50]  D. Naumann,et al.  Vergleich der trifluormethylierungseigenschaften von(CF3)Hg, CF3I und (CF3)2te am beispiel der reaktionen mit cyclohexen, benzol und pyridin , 1985 .

[51]  K. Joshi,et al.  Synthesis of some new fluorine‐containing 5‐amino‐1,3‐disubstituted pyrazoles and 1H‐pyrazolo[3,4‐b]pyridines , 1979 .

[52]  R. Soliman.  Preparation and antidiabetic activity of some sulfonylurea derivatives of 3,5-disubstituted pyrazoles. , 1979, Journal of medicinal chemistry.

[53]  I. Poláček,et al.  Potential antidiabetic agents. Pyrazolo(3,4-b)pyridines. , 1973, Journal of medicinal chemistry.

[54]  H. Dorn,et al.  Pyrazolo[3,4‐b]pyridines , 1967 .

[55]  P. Sharma,et al.  Inhibitors of apoptosis in testicular germ cells: synthesis and biological evaluation of some novel IBTs bearing sulfonamide moiety. , 2013, European journal of medicinal chemistry.

[56]  P. Sharma,et al.  Synthesis and Biological Evaluation of Some Novel Thiazolylhydrazinomethylideneferrocenes as Antimicrobial Agents , 2012 .

[57]  Saeed Rezaee,et al.  Correlation between lipophilicity and antimicrobial activity of some 2-(4-substituted phenyl)-3(2H)-isothiazolones , 2009 .

[58]  H. Castro,et al.  Synthesis, in vitro evaluation, and SAR studies of a potential antichagasic 1H-pyrazolo[3,4-b]pyridine series. , 2007, Bioorganic & Medicinal Chemistry.

[59]  H. Sachdev,et al.  Thiopegan derivatives—XXII , 1961 .